PortfoliosLab logoPortfoliosLab logo
VOR vs. VTSAX
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

VOR vs. VTSAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vor Biopharma Inc. (VOR) and Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

VOR vs. VTSAX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
VOR
Vor Biopharma Inc.
36.39%-41.08%-50.67%-66.17%-42.77%-69.01%
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
-6.75%17.12%23.23%26.51%-19.52%19.92%

Returns By Period

In the year-to-date period, VOR achieves a 36.39% return, which is significantly higher than VTSAX's -6.75% return.


VOR

1D
21.36%
1M
15.54%
YTD
36.39%
6M
-63.38%
1Y
24.32%
3Y*
-45.06%
5Y*
-52.97%
10Y*

VTSAX

1D
-0.46%
1M
-7.71%
YTD
-6.75%
6M
-4.47%
1Y
14.76%
3Y*
16.69%
5Y*
10.11%
10Y*
13.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VOR vs. VTSAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOR
VOR Risk / Return Rank: 5959
Overall Rank
VOR Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
VOR Sortino Ratio Rank: 7676
Sortino Ratio Rank
VOR Omega Ratio Rank: 7979
Omega Ratio Rank
VOR Calmar Ratio Rank: 4747
Calmar Ratio Rank
VOR Martin Ratio Rank: 4545
Martin Ratio Rank

VTSAX
VTSAX Risk / Return Rank: 4646
Overall Rank
VTSAX Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
VTSAX Sortino Ratio Rank: 4545
Sortino Ratio Rank
VTSAX Omega Ratio Rank: 4949
Omega Ratio Rank
VTSAX Calmar Ratio Rank: 4141
Calmar Ratio Rank
VTSAX Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VOR vs. VTSAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VORVTSAXDifference

Sharpe ratio

Return per unit of total volatility

0.13

0.84

-0.71

Sortino ratio

Return per unit of downside risk

1.89

1.29

+0.60

Omega ratio

Gain probability vs. loss probability

1.27

1.20

+0.08

Calmar ratio

Return relative to maximum drawdown

0.21

1.05

-0.84

Martin ratio

Return relative to average drawdown

0.32

5.08

-4.76

VOR vs. VTSAX - Sharpe Ratio Comparison

The current VOR Sharpe Ratio is 0.13, which is lower than the VTSAX Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of VOR and VTSAX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


VORVTSAXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.13

0.84

-0.71

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.45

0.59

-1.04

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.72

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.44

0.43

-0.87

Correlation

The correlation between VOR and VTSAX is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

VOR vs. VTSAX - Dividend Comparison

VOR has not paid dividends to shareholders, while VTSAX's dividend yield for the trailing twelve months is around 1.20%.


TTM20252024202320222021202020192018201720162015
VOR
Vor Biopharma Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VTSAX
Vanguard Total Stock Market Index Fund Admiral Shares
1.20%1.11%1.26%1.42%1.65%1.20%1.41%1.76%2.03%1.71%1.92%1.98%

Drawdowns

VOR vs. VTSAX - Drawdown Comparison

The maximum VOR drawdown since its inception was -99.72%, which is greater than VTSAX's maximum drawdown of -55.33%. Use the drawdown chart below to compare losses from any high point for VOR and VTSAX.


Loading graphics...

Drawdown Indicators


VORVTSAXDifference

Max Drawdown

Largest peak-to-trough decline

-99.72%

-55.33%

-44.39%

Max Drawdown (1Y)

Largest decline over 1 year

-87.15%

-12.41%

-74.74%

Max Drawdown (5Y)

Largest decline over 5 years

-99.61%

-25.36%

-74.25%

Max Drawdown (10Y)

Largest decline over 10 years

-34.97%

Current Drawdown

Current decline from peak

-98.35%

-8.92%

-89.43%

Average Drawdown

Average peak-to-trough decline

-88.36%

-9.06%

-79.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.88%

2.56%

+55.32%

Volatility

VOR vs. VTSAX - Volatility Comparison

Vor Biopharma Inc. (VOR) has a higher volatility of 29.30% compared to Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX) at 4.39%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than VTSAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


VORVTSAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.30%

4.39%

+24.91%

Volatility (6M)

Calculated over the trailing 6-month period

104.24%

9.33%

+94.91%

Volatility (1Y)

Calculated over the trailing 1-year period

187.43%

18.42%

+169.01%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

117.27%

17.32%

+99.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

118.05%

18.37%

+99.68%